Similar articles

• Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.

  Shaheen NJ, Spechler SJ. Shaheen NJ, et al. Endoscopy. 2008 Dec;40(12):994-9. doi: 10.1055/s-2008-1077785. Epub 2008 Dec 8. Endoscopy. 2008. PMID: 19065482 Review. No abstract available.
• [Pathogenesis and epidemiology of Barrett esophagus].

  Spechler SJ. Spechler SJ. Chirurg. 1994 Feb;65(2):84-7. Chirurg. 1994. PMID: 8162820 Review. German. No abstract available.
• Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.

  Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL. Dulai GS, et al. Am J Gastroenterol. 2005 Apr;100(4):775-83. doi: 10.1111/j.1572-0241.2005.41300.x. Am J Gastroenterol. 2005. PMID: 15784018
• Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.

  Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer J, Peters JH, Danenberg KD, Demeester TR, Danenberg PV. Lord RV, et al. J Thorac Cardiovasc Surg. 2003 Feb;125(2):246-53. doi: 10.1067/mtc.2003.203. J Thorac Cardiovasc Surg. 2003. PMID: 12579092
• [Early esophageal carcinoma: diagnosis and endoscopic therapy].

  Ell C. Ell C. Z Gastroenterol. 2002 Dec;40 Suppl 2:12-4. doi: 10.1055/s-2002-35900. Z Gastroenterol. 2002. PMID: 12466997 German. No abstract available.